Association of inflammaging (inflammation + aging) with higher prevalence of OAB in elderly population

International Urology and Nephrology

Volumn 46, Issue 5, 2014, Pages 871-877

  Tyagi, Pradeep ^a   Tyagi, Vikas ^b   Qu, Xianggui ^c   Lin, Hsin Tzu ^d   Kuo, Hann Chorng ^d   Chuang, Yao Chi ^e   Chancellor, Michael ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c OAKLAND UNIVERSITY   (United States)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Aging; Chemokines; Immunoassay; Inflammation; Urine

Indexed keywords

CHEMOKINE; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; PROTEOME; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN;

ADULT; AGED; AGING; ARTICLE; BLADDER; BLADDER FUNCTION; CONTROLLED STUDY; CORRELATION COEFFICIENT; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INFLAMMATION; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVERACTIVE BLADDER; PREVALENCE; PROTEIN URINE LEVEL; RISK FACTOR; UNIVARIATE ANALYSIS; URINALYSIS; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; MALE; MIDDLE AGED; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHEMOKINES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; URINALYSIS; URINARY BLADDER, OVERACTIVE;

EID: 84903694958     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0621-x     Document Type: Article

References (35)

1. Giunta B, Fernandez F, Nikolic WV, Obregon D, Rrapo E, Town T, Tan J (2008) Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation 5:51. doi:10.1186/1742-2094-5-51
2. Chang SS, Vaz Fragoso CA, Van Ness PH, Fried LP, Tinetti ME (2011) Association between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women's Health and Aging Studies I and II. J Am Geriatr Soc 59(1):113-119. doi:10.1111/j.1532-5415.2010. 03203.x
3. Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, Chapple CR, Kaplan S, Tubaro A, Aiyer LP, Wein AJ (2009) The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 104(3):352-360. doi:10.1111/j.1464-410X.2009.08427.x
4. Yoshida M (2009) Perspectives on overactive bladder in the elderly population. World J Urol 27(6):729-737. doi:10.1007/s00345-009-0491-0
5. Santos ML, Gomes WF, Pereira DS, Oliveira DM, Dias JM, Ferrioli E, Pereira LS (2011) Muscle strength, muscle balance, physical function and plasma interleukin-6 (IL-6) levels in elderly women with knee osteoarthritis (OA). Arch Gerontol Geriatr 52(3):322-326. doi:10.1016/j.archger.2010.05.009
6. Yoshida Y, Iwasa H, Kumagai S, Yoshida H, Suzuki T (2010) Association between C-reactive protein (CRP) level and physical performance in community-dwelling elderly in Japan. Arch Gerontol Geriatr 51(2):164-168. doi:10.1016/j.archger.2009.10.002
7. Blain H, Jaussent A, Beziat S, Dupuy AM, Bernard PL, Mariano-Goulart D, Cristol JP, Sultan C, Picot MC (2012) Low serum IL-6 is associated with high 6-minute walking performance in asymptomatic women aged 20 to 70 years. Exp Gerontol 47(2):143-148. doi:10.1016/j.exger.2011.11.008
8. Zhao W, Aboushwareb T, Turner C, Mathis C, Bennett C, Sonntag WE, Andersson KE, Christ G (2010) Impaired bladder function in aging male rats. J Urol 184(1):378-385. doi:10.1016/j.juro.2010.03.004
9. Gomez-Pinilla PJ, Pozo MJ, Camello PJ (2011) Aging differentially modifies agonist-evoked mouse detrusor contraction and calcium signals. Age (Dordr) 33(1):81-88. doi:10.1007/s11357-010-9163-7
10. Pagala MK, Tetsoti L, Nagpal D, Wise GJ (2001) Aging effects on contractility of longitudinal and circular detrusor and trigone of rat bladder. J Urol 166(2):721-727 (Pubitemid 32652307)
11. Tyagi P, Killinger K, Tyagi V, Nirmal J, Chancellor M, Peters KM (2012) Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis. J Urol 187(6):2243-2248. doi:10.1016/j.juro.2012.01.034
12. Guzzo TJ, Drach GW (2010) Major urologic problems in geriatrics: assessment and management. Med Clin North Am 95(1):253-264. doi:10.1016/j.mcna. 2010.08.026
13. Jacobs BL, Smaldone MC, Tyagi V, Philips BJ, Jackman SV, Leng WW, Tyagi P (2010) Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients. Can J Urol 17(1):4989-4994
14. Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y, Chancellor M (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42(3):629-635. doi:10.1007/s11255-009-9647-5
15. Kuo HC, Liu HT, Chancellor MB (2010) Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourol Urodyn 29(3):482-487. doi:10.1002/nau.20741
16. Arms L, Girard BM, Malley SE, Vizzard MA (2013) Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation. Am J Physiol Renal Physiol 305(1):F111-F122. doi:10.1152/ajprenal.00139.2013
17. Auge C, Chene G, Dubourdeau M, Desoubzdanne D, Corman B, Palea S, Lluel P, Vergnolle N, Coelho AM (2013) Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder. Eur J Pharmacol 707(1-3):32-40. doi:10.1016/j.ejphar.2013.03.008
18. Lv J, Huang Y, Zhu S, Yang G, Zhang Y, Leng J, Bo J, Liu D (2012) MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/bladder pain syndrome in rat models. Mediators Inflamm 2012:358184. doi:10.1155/2012/358184
19. Ochodnicky P, Cruz CD, Yoshimura N, Cruz F (2012) Neurotrophins as regulators of urinary bladder function. Nat Rev Urol 9(11):628-637. doi:10.1038/nrurol.2012.178
20. Yoshimura N, Bennett NE, Hayashi Y, Ogawa T, Nishizawa O, Chancellor MB, de Groat WC, Seki S (2006) Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J Neurosci: Off J Soc Neurosci 26(42):10847-10855. doi:10.1523/JNEUROSCI.3023-06. 2006
21. Tyagi P, Tyagi V, Bui D, Qu H, Peters K, Chuang Y-C, Kuo H-C, Yoshimura N, Chancellor M (2010) Discrimination of OAB from IC/PBS By multivariate data modeling of urinary proteins. J Urol 183(4, Supplement):e614-e615. doi:10.1016/j.juro.2010.02.1368
22. Tyagi V, Qu H, Peters K, Chuang Y-C, Kuo H-C, Yoshimura N, Tyagi S, Chancellor M, Tyagi P (2011) Age associated changes in urinary proteome of OAB patients. J Urol 185 (4, Supplement): e781. doi:10.1016/j.juro.2011.02.2158
23. Kashyap M, Kawamorita N, Tyagi V, Sugino Y, Chancellor M, Yoshimura N, Tyagi P (2013) Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder. J Urol 190(2):757-764. doi:10.1016/j.juro.2013.02.090
24. Lamb K, Gebhart GF, Bielefeldt K (2004) Increased nerve growth factor expression triggers bladder overactivity. J Pain 5(3):150-156 (Pubitemid 38879393)
25. Bierl MA, Isaacson LG (2007) Increased NGF proforms in aged sympathetic neurons and their targets. Neurobiol Aging 28(1): 122-134. doi:10.1016/j. neurobiolaging.2005.11.008 (Pubitemid 44791641)
26. Taylor JA 3rd, Kuchel GA (2006) Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc 54(12):1920-1932. doi:10.1111/j.1532-5415.2006.00917.x
27. Liu HT, Chancellor MB, Kuo HC (2009) Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 103(12):1668-1672. doi:10.1111/j.1464-410X.2009.08380.x
28. Semirale AA, Zhang XW, Wiren KM (2011) Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation. J Cell Biochem 112(7):1773-1786. doi:10.1002/jcb.23098
29. Meijer K, de Vries M, Al-Lahham S, Bruinenberg M, Weening D, Dijkstra M, Kloosterhuis N, van der Leij RJ, van der Want H, Kroesen BJ, Vonk R, Rezaee F (2011) Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One 6(3):e17154. doi:10.1371/journal.pone.0017154
30. Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, Kumar A (2010) Tumor necrosis factor-alpha regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS One 5(10):e13262. doi:10.1371/journal.pone.0013262
31. Rybka J, Kupczyk D, Kedziora-Kornatowska K, Pawluk H, Czuczejko J, Szewczyk-Golec K, Kozakiewicz M, Antonioli M, Carvalho LA, Kedziora J (2011) Age-related changes in an antioxidant defense system in elderly patients with essential hypertension compared with healthy controls. Redox Rep 16(2):71-77. doi:10.1179/174329211X13002357050897
32. Tajar A, O'Connell MD, Mitnitski AB, O'Neill TW, Searle SD, Huhtaniemi IT, Finn JD, Bartfai G, Boonen S, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Rockwood K, Wu FC (2011) Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study. J Am Geriatr Soc 59(5):814-821. doi:10.1111/j.1532- 5415.2011.03398.x
33. Otto G, Burdick M, Strieter R, Godaly G (2005) Chemokine response to febrile urinary tract infection. Kidney Int 68(1): 62-70. doi:10.1111/j.1523- 1755.2005.00381.x (Pubitemid 43181364)
34. Tyagi P, Tyagi V, Qu H, Peters K, Chuang Y-C, Liu H-T, Kuo H-C, Chancellor M (2011) Urine analysis of confirmed UTI patients reveal higher levels of CXC chemokines compared to patients with LUTS without UTI. J Urol 185(4, Supplement): e547. doi:10.1016/j.juro.2011.02.1194
35. Goto M (2008) Inflammaging (inflammation + aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends 2(6):218-230